(DOI:10.1016/j.mednuc.2007.06.008);What is the meaning of abnormalities observed on bone scintigraphy?. Bisphosphonates-(99mTc) mechanisms of uptake revisited;Quelle est la signification des anomalies observées en scintigraphie osseuse ?. Retour sur les mécanismes de fixation des bisphosphonates-(99mTc)

Medecine Nucleaire

Volumn 31, Issue 7, 2007, Pages 356-365

  Paycha, Frédéric ^a   Maia, Serge ^a   Ayachi, Najla ^a   Grossin, Maggy ^a   de Vernejoul, Marie Christine ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bone disorders; Bone scintigraphy; Radio labelled bisphosphonates; Semiology; Therapeutic bisphosphonates

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID TC 99M; IBANDRONIC ACID; INCADRONIC ACID; MEDRONIC ACID; MINERAL; NERIDRONIC ACID; OXIDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; RISEDRONIC ACID; TECHNETIUM 99M; TILUDRONIC ACID; ZOLEDRONIC ACID;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; DRUG ABSORPTION; DRUG MECHANISM; DRUG STRUCTURE; FIBROUS DYSPLASIA; HUMAN; IN VITRO STUDY; INTERNALIZATION; MYELOMA; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PAGET BONE DISEASE;

ANIMALIA;

EID: 34547738967     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2007.10.005     Document Type: Erratum

References (31)

1. Watanabe H., Sato T., Hisinuma T., and Ogata Y. Comparison of MRI, CT and bone scintigraphy in metastases of experimental neoplasm. Tohoku J Exp Med 163 (1991) 229-231
2. Rodan G.A., and Fleisch H.A. Bisphosphonates: mechanisms of action. J Clin Invest 97 (1996) 2692-2696
3. Schwartz Z., Shani J., Soskolne W.A., Touma H., Amir D., and Sela J. Uptake and biodistribution of technetium-99m-MD32P during rat tibial bone repair. J Nucl Med 34 (1993) 104-108
4. Goltzman D. Osteolysis and cancer. J Clin Invest 107 (2001) 1219-1220
5. Yin J.J., Pollock C.B., and Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res 15 (2005) 57-62
6. Matsumoto T., and Abe M. Bone destruction in multiple myeloma. Ann N Y Acad Sci 1068 (2006) 319-326
7. Gligorov J., and Clézardin P. Bisphosphonates et cancer : mécanismes d'action et indications cliniques dans l'ostéolyse maligne. Lett Cancérol 9 (2000) 36-44
8. Comet M., and Maublant J. Radiopharmaceutiques à tropisme osseux. In: Comet M., and Vidal M. (Eds). Radiopharmaceutiques - Chimie des radiotraceurs et applications biologiques (1998), Presses Universitaires de Grenoble, Grenoble 485-493
9. Watt L., and Hill P. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat. Brit J Radiol 54 (1981) 592-596
10. Paycha F., Ramadan A., Rezgui M., Félice K., and Giraud C. Impact des bisphosphonates thérapeutiques sur la scintigraphie osseuse aux bisphosphonates radiomarqués. Oncoscopie 8 (2002) 14-22
11. Paycha F, Richard B. Exploration scintigraphique du squelette. Encycl Méd Chir (Éditions Scientifiques et Médicales Elsevier SAS, Paris), Radiodiagnostic-Squelette normal, 30-480-A-10, 2001, 37 p.
12. Decroisette C. Le traitement des métastases osseuses par les biphosphonates. Méd Nucl 30 (2006) 164-171
13. Guillemart A., Le Pape A., Galy G., and Besnard J.C. Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation. J Nucl Med 31 (1990) 466-470
14. Kaye M., Silverton S., and Rosenthall L. Technetium-99m-pyrophosphate: studies in vivo and in vitro. J Nucl Med 16 (1975) 40-45
15. Einhorn T., Vigorita V.J., and Aaron A. Localization of technetium-99m methylene diphosphonate in bone using microautoradiography. J Orthop Res 4 (1986) 180-187
16. Toegel S., Hoffmann O., Wadsak W., Ettlinger D., Mien L.K., Wiesner K., et al. Uptake of bone-seekers is solely associated with mineralization. A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts. Eur J Nucl Med Mol Imaging 33 (2006) 491-494
17. Loutfi I., Collier B.D., and Mohammed A.M. Nonosseous abnormalities on bone scans. J Nucl Med Technol 31 (2003) 149-156
18. Boissier S., Magnetto S., Frappart L., Cuzin B., Ebetino F.H., Delmas P.D., et al. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res 57 (1997) 3890-3894
19. Passeri G., Girasole G., and Guiliani N. The effect of bisphosphonates on the secretion of IL6 by the MG-63 osteoblastic cell line and the formation of CFU-F and CFU-OB in murine bone marrow. Bone 16 (1995) 169
20. Rogers M.J. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 75 (2004) 451-461
21. Sahni M., Guenther H.L., Fleisch H., Collin P., and Martin T.J. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91 (1993) 2004-2011
22. Shipman C.M., Rogers M.J., Apperley J.F., Russell R.G., and Croucher P.I. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumor activity. Br J Haematol 98 (1997) 665-672
23. Salgia R., Demetri G.D., and Kaplan W.D. Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. Cancer 74 (1994) 1887-1890
24. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
25. Hirbe A.C., Uluçkan O., Morgan E.A., Eagleton M.C., Prior J.L., Piwnica, et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood 109 (2007) 3424-3431
26. Joshua F., Epstein M., and Major G. Bisphosphonates resistance in Paget's disease of bone. Arthritis Rheum 48 (2003) 2321-2323
27. Cohen M. The new bone biology: pathologic, molecular and clinical correlates. Am J Med Genet Part A 140 (2006) 2646-2706
28. Terpstra L., Rauch F., Plotkin H., Travers R., and Glorieux F.H. Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis. J Bone Miner Res 17 (2002) 1949-1953
29. Riminucci M., Saggio I., Gehron Robey P., and Bianco P. Fibrous dysplasia as a stem cell disease. J Bone Miner Res 21 (2006) P125-P131
30. Kransdorf M.J., Moser Jr. R.P., and Gilkey F.W. Fibrous dysplasia. Radiographics 10 (1990) 519-537
31. Machida K., Makita K., Nishikawa J., Ohtake T., and Iio M. Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med 11 (1986) 426-429